keyword
https://read.qxmd.com/read/38634047/case-report-characteristics-and-nature-of-primary-cardiac-synovial-sarcoma
#1
Tomonori Kawasaki, Tomomi Nakajima, Tomoaki Torigoe, Kojiro Onohara, Kentaro Ishii, Satoshi Kanno, Chisako Muramatsu, Rikito Tatsuno, Takahiro Jubashi, Jiro Ichikawa
Primary malignant cardiac tumors rarely occur, and cardiac synovial sarcoma (SS) is especially rare among such tumors. Herein, we present the case of a 35-year-old female with primary cardiac SS treated with surgery, chemotherapy, and radiotherapy. She presented with chest symptoms and underwent imaging examinations. A cardiac tumor was suspected, and an open biopsy was performed. The pathological findings suggested cardiac SS. Next, we performed a resection, and the tumors persisted at a macroscopic level...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38558649/genomic-analysis-of-undifferentiated-carcinoma-of-the-pancreas-with-squamous-differentiation-a-case-report
#2
Motoyasu Kan, Yusuke Kouchi, Hiroshi Ohyama, Genki Usui, Masaki Fukuyo, Shigetsugu Takano, Takashi Kishimoto, Atsushi Kaneda, Masayuki Ohtsuka, Naoya Kato
Pancreatic cancer is an intractable malignancy associated with a dismal prognosis. Undifferentiated carcinoma, a rare subtype, poses a clinical challenge owing to a limited understanding of its molecular characteristics. In this study, we conducted genomic analysis specifically on a case of undifferentiated carcinoma of the pancreas exhibiting squamous differentiation. An 80-year-old male, previously treated for colorectal cancer, presented with a mass with central cystic degeneration in the pancreatic tail...
February 2024: Curēus
https://read.qxmd.com/read/38556389/radiation-therapy-for-the-management-of-renal-medullary-carcinoma-a-multi-case-study
#3
Robert H Mbilinyi, Pavlos Msaouel, Priya Rao, Jose A Karam, Nizar M Tannir, Chad Tang
No abstract text is available yet for this article.
March 5, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38538798/targeting-dcaf5-suppresses-smarcb1-mutant-cancer-by-stabilizing-swi-snf
#4
JOURNAL ARTICLE
Sandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, Raymond D Carter, Alexis N Robertson, Priya Mittal, Zhexin Zhu, Baranda S Hansen, Katherine A Donovan, Moritz Hunkeler, Wojciech Rosikiewicz, Zhiping Wu, Meghan G McReynolds, Shourya S Roy Burman, Anna M Schmoker, Nada Mageed, Scott A Brown, Robert J Mobley, Janet F Partridge, Elizabeth A Stewart, Shondra M Pruett-Miller, Behnam Nabet, Junmin Peng, Nathanael S Gray, Eric S Fischer, Charles W M Roberts
Whereas oncogenes can potentially be inhibited with small molecules, the loss of tumour suppressors is more common and is problematic because the tumour-suppressor proteins are no longer present to be targeted. Notable examples include SMARCB1-mutant cancers, which are highly lethal malignancies driven by the inactivation of a subunit of SWI/SNF (also known as BAF) chromatin-remodelling complexes. Here, to generate mechanistic insights into the consequences of SMARCB1 mutation and to identify vulnerabilities, we contributed 14 SMARCB1-mutant cell lines to a near genome-wide CRISPR screen as part of the Cancer Dependency Map Project1-3 ...
March 27, 2024: Nature
https://read.qxmd.com/read/38528688/soy-derived-isoflavones-as-chemo-preventive-agents-targeting-multiple-signalling-pathways-for-cancer-prevention-and-therapy
#5
REVIEW
Agnieszka Kaufman-Szymczyk, Justyna Jalmuzna, Katarzyna Lubecka-Gajewska
The chemopreventive and chemotherapeutic properties of soy and soy-derived compounds, especially isoflavones, have been extensively studied in recent years. However, in contrast to their anticancer effects, such as cell growth inhibition, cell cycle arrest and apoptosis induction, isoflavones have also been found to promote the growth of cancer cells. Therefore, the aim of this comprehensive review article is to present the current state of knowledge regarding the molecular mechanisms by which soy-derived isoflavones target multiple cellular signalling pathways in cancer cells...
March 25, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38527786/a-mass-in-the-pineal-region-of-a-young-woman
#6
Lorraina J Robinson, Eric Goold, David Anderson, Robert C Rennert, William T Couldwell, Changhong Xing
No abstract text is available yet for this article.
March 25, 2024: Brain Pathology
https://read.qxmd.com/read/38527168/four-distinct-ipsilateral-vestibular-schwannomas-a-case-of-mosaic-nf2-related-schwannomatosis
#7
JOURNAL ARTICLE
Alexandra E Tunkel, Emily R Youner, Hayk Barseghyan, Yulong Fu, Surajit Bhattacharya, Miriam Bornhorst, Ashkan S Monfared
OBJECTIVES: Distinguishing between sporadic and germline/mosaic NF2-related schwannomatosis is important to ensure that patients have appropriate long-term care. With this report, we describe a unique case of a patient with 4 ipsilateral schwannomas and identify a combination of sequencing modalities that can accurately diagnose mosaic NF2-related schwannomatosis. METHODS: We present a 32-year-old woman with a familial history of vestibular schwannoma in her father and right-sided schwannomas involving the apical and basal turns of cochlea, lateral semicircular canal, and internal auditory canal (IAC)...
March 25, 2024: American Journal of Clinical Pathology
https://read.qxmd.com/read/38522153/assessment-of-targeted-therapy-opportunities-in-sinonasal-cancers-using-patient-derived-functional-tumor-models
#8
JOURNAL ARTICLE
Noora Lehtinen, Janne Suhonen, Kiesha Rice, Eetu Välimäki, Mervi Toriseva, Johannes Routila, Perttu Halme, Melissa Rahi, Heikki Irjala, Ilmo Leivo, Markku Kallajoki, Matthias Nees, Teijo Kuopio, Sami Ventelä, Juha K Rantala
UNLABELLED: Malignant tumors derived from the epithelium lining the nasal cavity region are termed sinonasal cancers, a highly heterogeneous group of rare tumors accounting for 3 - 5 % of all head and neck cancers. Progress with next-generation molecular profiling has improved our understanding of the complexity of sinonasal cancers and resulted in the identification of an increasing number of distinct tumor entities. Despite these significant developments, the treatment of sinonasal cancers has hardly evolved since the 1980s, and an advanced sinonasal cancer presents a poor prognosis as targeted therapies are usually not available...
March 23, 2024: Translational Oncology
https://read.qxmd.com/read/38519377/the-new-who-category-of-molecularly-defined-renal-carcinomas-clinical-and-diagnostic-features-and-management-implications
#9
REVIEW
Jonathan Kanakaraj, Justin Chang, Lance J Hampton, Steven Christopher Smith
The evolution of classification of renal tumors has been impacted since the turn of the millennium by rapid progress in histopathology, immunohistochemistry, and molecular genetics. Together, these features have enabled firm recognition of specific, classic types of renal cell carcinomas, such as clear cell renal cell carcinoma, that in current practice trigger histologic-type specific management and treatment protocols. Now, the fifth Edition World Health Classification's new category of "Molecularly defined renal carcinomas" changes the paradigm, defining a total of seven entities based specifically on their fundamental molecular underpinnings...
March 21, 2024: Urologic Oncology
https://read.qxmd.com/read/38501690/molecularly-defined-thoracic-neoplasms
#10
JOURNAL ARTICLE
Anja C Roden
Molecularly defined neoplasms are increasingly recognized, given the broader application and performance of molecular studies. These studies allow us to better characterize these neoplasms and learn about their pathogenesis. In the thorax, molecularly defined neoplasms include tumors such as NUT carcinoma, SMARCA4-deficient undifferentiated tumor (DUT), primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion, hyalinizing clear cell carcinoma, and SMARCB1-deficient neoplasms. Overall, these tumors are rare but are now more often recognized given more widely available immunostains such as NUT (NUT carcinoma), BRG1 (SMARCA4-DUT), and INI-1 (SMARCB1-deficient neoplasm)...
March 19, 2024: Advances in Anatomic Pathology
https://read.qxmd.com/read/38497146/smarca4-deficient-undifferentiated-tumor-of-the-esophagus-diagnostic-pitfalls-in-immunohistochemical-profiles
#11
JOURNAL ARTICLE
Rana Chakrabarti, Sherman Lin, Hui Wang, Matthew Cecchini
SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) are a newly described entity and are typically seen in the thoracic cavity. However, these tumors have been described in other body sites, including the esophagus. These tumors are rare, aggressive neoplasms, characterized by the loss of protein product of SMARCA4 (Brahma-related gene-1) and the preservation of INI1 (SMARCB1) expression. Here, we present two tumors of SMARCA4-UT of the esophagus with its microscopic appearance and immunohistochemical profile...
March 18, 2024: International Journal of Surgical Pathology
https://read.qxmd.com/read/38488196/atypical-teratoid-rhabdoid-tumour-tyr-subtype-arising-in-the-setting-of-germline-ring-chromosome-22-an-uncommon-form-of-tumour-predisposition
#12
JOURNAL ARTICLE
Julieann C Lee, Quynh T Tran, Rose B McGee, Melissa R Perrino, Santhosh A Upadhyaya, Emily M Hanzlik, Nicholas Pytel, Andrew J Carroll, Wilda Orisme, Mohammad Eldomery, Lu Wang, Patrick R Blackburn, Larissa V Furtado, Angela N Viaene, Minjie Luo, Jennifer M Kalish, Soniya N Pinto, Asim K Bag, Brent A Orr
No abstract text is available yet for this article.
April 2024: Neuropathology and Applied Neurobiology
https://read.qxmd.com/read/38487122/high-grade-atypical-teratoid-rhabdoid-tumor-in-the-pituitary-region
#13
Vincent S Alexander, Michael Ernst, Wang L Cheung, Alyssa N Obermiller, Catherine Mercado, Hermes Garcia, Kavita M Pattani
Atypical teratoid/rhabdoid tumors (AT/RTs) are embryological tumors of the central nervous system (CNS). They are typically found in children, with rare presentations in adults. We describe the presentation of an AT/RT in the pituitary region of a 37-year-old female. The patient presented with a two-week history of intractable cephalgia with sudden onset of monocular diplopia and left-sided cranial nerve VI palsy. The patient underwent transsphenoidal resection of their mass, which revealed the diagnosis...
February 2024: Curēus
https://read.qxmd.com/read/38476782/next-generation-dna-sequencing-of-grade-1-meningioma-tumours-a-case-report-of-angiomatous-and-psammomatous-meningiomas
#14
Mohiuddin M Taher, Khalid M Ashour, Bashayer A Althaqafi, Albatool Mansouri, Arwa A Al-Harbi, Weam Filfilan, Ghassan Y Bakhsh, Najwa A Bantan, Muhammad Saeed, Khalid AlQuthami
We performed the next-generation sequencing (NGS) analysis of a rare grade 1 brain meningioma (angiomatous type) and a common grade 1 spinal meningioma (psammomatous type) and compared their mutation profiling. The data were analysed using the Ion Reporter 5.16 programme (Thermo Fisher Scientific, Waltham, MA). Sequencing analysis identified 10 novel variants and two previously reported variants that were common between these two tumours. Nine variants were missense, which included an insertion in EGFR c.1819_1820insCA, causing frameshifting, and a single nucleotide deletion in HRAS and HNF1A genes, causing frameshifting in these genes...
February 2024: Curēus
https://read.qxmd.com/read/38473416/dynamic-survival-risk-prognostic-model-and-genomic-landscape-for-atypical-teratoid-rhabdoid-tumors-a-population-based-real-world-study
#15
JOURNAL ARTICLE
Sihao Chen, Yi He, Jiao Liu, Ruixin Wu, Menglei Wang, Aishun Jin
BACKGROUND: An atypical teratoid/rhabdoid tumor (AT/RT) is an uncommon and aggressive pediatric central nervous system neoplasm. However, a universal clinical consensus or reliable prognostic evaluation system for this malignancy is lacking. Our study aimed to develop a risk model based on comprehensive clinical data to assist in clinical decision-making. METHODS: We conducted a retrospective study by examining data from the Surveillance, Epidemiology, and End Results (SEER) repository, spanning 2000 to 2019...
March 5, 2024: Cancers
https://read.qxmd.com/read/38473277/super-enhancer-dysregulation-in-rhabdoid-tumor-cells-is-regulated-by-the-swi-snf-atpase-brg1
#16
JOURNAL ARTICLE
Cheyenne A Jones, Jing Wang, James R Evans, Hannah R Sisk, Carl B Womack, Qi Liu, William P Tansey, April M Weissmiller
Mutations in the SWI/SNF chromatin remodeling complex occur in ~20% of cancers. In rhabdoid tumors defined by loss of the SWI/SNF subunit SMARCB1 , dysregulation of enhancer-mediated gene expression is pivotal in driving oncogenesis. Enhancer dysregulation in this setting is tied to retention of the SWI/SNF ATPase BRG1-which becomes essential in the absence of SMARCB1 -but precisely how BRG1 contributes to this process remains unknown. To characterize how BRG1 participates in chromatin remodeling and gene expression in SMARCB1 -deficient cells, we performed a genome-wide characterization of the impact of BRG1 depletion in multiple rhabdoid tumor cell lines...
February 24, 2024: Cancers
https://read.qxmd.com/read/38472198/identifying-regulators-of-aberrant-stem-cell-and-differentiation-activity-in-colorectal-cancer-using-a-dual-endogenous-reporter-system
#17
JOURNAL ARTICLE
Sandor Spisak, David Chen, Pornlada Likasitwatanakul, Paul Doan, Zhixin Li, Pratyusha Bala, Laura Vizkeleti, Viktoria Tisza, Pushpamali De Silva, Marios Giannakis, Brian Wolpin, Jun Qi, Nilay S Sethi
Aberrant stem cell-like activity and impaired differentiation are central to the development of colorectal cancer (CRC). To identify functional mediators of these key cellular programs, we engineer a dual endogenous reporter system by genome-editing the SOX9 and KRT20 loci of human CRC cell lines to express fluorescent reporters, broadcasting aberrant stem cell-like and differentiation activity, respectively. By applying a CRISPR screen targeting 78 epigenetic regulators with 542 sgRNAs to this platform, we identify factors that contribute to stem cell-like activity and differentiation in CRC...
March 12, 2024: Nature Communications
https://read.qxmd.com/read/38467288/renal-medullary-carcinoma-%C3%A2-the-zebra-amongst-the-horses
#18
Deepansh Dalela, Shane Batie, Alexandra Carolan, Bruce Schlomer, Rebecca Collins, Micah Jacobs
A 13-year old Latino male presented with recurrent gross hematuria, 5cm right-sided poorly defined heterogeneous mass, enlarged retrocaval lymph nodes, and 1.2 cm paratracheal lymph node. Given the need for multiple blood transfusions, robot-assisted radical nephrectomy with lymph node dissection was performed. Pathology revealed pT3a high-grade tumor, clear margins, and positive lymph node. Additionally, with multiple sickled RBCs and loss of staining of SMARCB1 in tumor specimen, and hemoglobin electrophoresis suggesting sickle cell trait, diagnosis of metastatic renal medullary carcinoma was confirmed...
March 10, 2024: Urology
https://read.qxmd.com/read/38457069/primary-oropharyngeal-smarca4-deficient-carcinoma-expanding-the-diagnostic-spectrum-in-head-and-neck-cancer
#19
JOURNAL ARTICLE
Sunil Pasricha, Sumit Goyal, Meenakshi Kamboj, Himanshi Diwan, Munish Gairola, Jaskaran Singh Sethi, Manoj Gupta, Anurag Mehta
With the advent of molecular immunohistochemistry and next generation sequencing, Switch/sucrose non-fermentable (SWI/SNF) chromatin remodeling complex altered tumors have gained recognition recently. SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily B member 1 (SMARCB1) and SMARCA4 are the primary SWI/SNF components altered in several recently described undifferentiated malignancies in head and neck region with predilection for paranasal sinuses in SMARCB1-deficient tumors and nasal cavity in SMARCA4-deficient tumors...
March 8, 2024: Head and Neck Pathology
https://read.qxmd.com/read/38410173/two-cases-of-atypical-teratoid-rhabdoid-tumor-in-the-spinal-cord-loss-of-smarcb1-in-a-child-and-loss-of-smarca4-in-an-adult
#20
Tamaki Morisako, Daisuke Umebayashi, Toshiki Nagai, Takumi Yamanaka, Takanori Hirose, Yukiko Shishido-Hara, Eiich Konishi, Naoya Hashimoto
We compare two cases of primary spinal atypical teratoid/rhabdoid tumor (AT/RT), which rarely occurs in adults marked by SMARCA4 inactivation, and SMARCB1 inactivation for pediatric cases. AT/RT represents a highly malignant neoplasm comprising poorly differentiated constituents and rhabdoid cells, with SMARCB1(INI1) or infrequently SMARCA4 (BRG1) inactivation. These tumors are predominantly found in children but are rare in adults. While AT/RT can arise anywhere in the central nervous system, spinal cord localization is comparatively scarce...
2024: NMC Case Report Journal
keyword
keyword
165632
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.